American Association for Cancer Research

SHERPA: Unknown

People

  1. Rudin
    Rudin
  2. De Stanchina
    De Stanchina
  3. Ladanyi
    Ladanyi
  4. Kris
    Kris
  5. Riely
    Riely
  6. Arcila
    Arcila
  7. Offin
    Offin
  8. Rekhtman
    Rekhtman
  9. Berger
    Berger
  10. Drilon
    Drilon

Groups

  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (65)
  2. Center for Molecular Imaging and Biotechnology (CMIB) (65)
  3. Department of Medicine (65)
  4. GSK Faculty (65)
  5. Solid Tumor Oncology Division (65)
  6. Thoracic Oncology (65)
  7. Sloan Kettering Institute Postdocs (35)
  8. Department of Pathology and Laboratory Medicine (26)
  9. Hematology-Oncology Fellows (22)
  10. Weinberg Fellows (20)
Search Within
  1. "Charles Rudin"
Formats
  1. Journal Article (35)
  2. Meeting Abstract (28)
  3. Editorial (1)
  4. Guidelines (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (65)
  2. Center for Molecular Imaging and Biotechnology (CMIB) (65)
  3. Department of Medicine (65)
  4. GSK Faculty (65)
  5. Solid Tumor Oncology Division (65)
  6. Thoracic Oncology (65)

More Groups

People
  1. Charles Rudin (65)
  2. Elisa De Stanchina (14)
  3. John Poirier (13)
  4. Marc Ladanyi (13)
  5. Triparna Sen (11)
  6. Gregory Riely (10)

More People

Years
  1. 2025 (2)
  2. 2024 (1)
  3. 2023 (2)
  4. 2022 (15)
  5. 2021 (10)
  6. 2020 (8)

More Years

Publications
  1. Clinical Cancer Research (33)
  2. Cancer Research (32)

Results (65)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • RIT1 drives oncogenic transformation and is an actionable target in lung adenocarcinoma
    Journal Article

    Mozzarelli, A. M.; Cuevas-Navarro, A.; Shuldiner, E. G.; Vega, M.; Chatila, W. K.; Xu, J.; Walch, H. S.; Niu, Y. Z.; Petrov, D. A.; Schultz, N.; more...
    Cancer Research (2025)

    Fulltext@MSK | Save
  • The lung cancer autochthonous model gene expression database enables cross-study comparisons of the transcriptomic landscapes across mouse models
    Journal Article

    Cai, L.; Wu, F.; Zhou, Q.; Gao, Y.; Yao, B.; DeBerardinis, R. J.; Acquaah-Mensah, G. K.; Aidinis, V.; Beane, J. E.; Biswal, S.; more...
    Cancer Research (2025)

    Fulltext@MSK | Save
  • A phase I/II study of valemetostat (DS-3201b), an EZH1/2 inhibitor, in combination with irinotecan in patients with recurrent small-cell lung cancer
    Journal Article

    Choudhury, N. J.; Lai, W. V.; Makhnin, A.; Heller, G.; Eng, J.; Li, B.; Preeshagul, I.; Santini, F. C.; Offin, M.; Ng, K.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Clinical and molecular features of long-term response to immune checkpoint inhibitors in patients with advanced non–small cell lung cancer
    Journal Article

    Thummalapalli, R.; Ricciuti, B.; Bandlamudi, C.; Muldoon, D.; Rizvi, H.; Elkrief, A.; Luo, J.; Alessi, J. V.; Pecci, F.; Lamberti, G.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • De novo and histologically transformed small-cell lung cancer is sensitive to lurbinectedin treatment through the modulation of EMT and NOTCH signaling pathways
    Journal Article

    Chakraborty, S.; Coleman, C.; Manoj, P.; Demircioglu, D.; Shah, N.; de Stanchina, E.; Rudin, C. M.; Hasson, D.; Sen, T.
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Durvalumab (D) + platinum-etoposide (EP) in 1L extensive-stage small-cell lung cancer (ES-SCLC): Exploratory analysis of SCLC molecular subtypes in CASPIAN
    Meeting Abstract

    Xie, M.; Chugh, P.; Broadhurst, H.; Lai, Z.; Whitston, D.; Paz-Ares, L.; Gay, C.; Byers, L.; Rudin, C. M.; Stewart, R.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Profiling of the circulating cell-free DNA methylome for detection and subtyping of small cell lung cancers
    Meeting Abstract

    Rothwell, D. G.; Chemi, F.; Pearce, S.; Clipson, A.; Hill, S.; Conway, A. M.; Richardson, S.; Murat, K.; Caeser, R.; Egger, J.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Characterizing SMARCA4/STK11/KEAP1 co-mutant lung adenocarcinoma
    Meeting Abstract

    Costa, E.; Wohlheiter, C.; Tischfield, S.; Funnell, A.; Poirier, J. T.; Villalonga, A. Q.; Sen, T.; Rudin, C.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Ferroptosis evasion as a therapeutic strategy in STK11/KEAP1 co-mutant lung adenocarcinoma
    Meeting Abstract

    Durani, V.; Wohlhieter, C. A.; Quintanal-Villalonga, A.; Sen, T.; Manoj, P.; Rudin, C. M.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • A quantitative in vivo pharmacogenomics platform uncovers biomarkers of therapy response
    Meeting Abstract

    Rosen, M.; Amar, D.; Winters, I.; Rizvi, H.; Nie, W.; Wall, G.; Petrov, D.; Winslow, M.; Rudin, C.; Juan, J.
    Cancer Research (2022)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: